Lucia B. Jilaveanu

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 21 papers. Top paper: “Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial”.

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30111-x

N/A

6.6DataRank · unranked

541 citations

Kurt A. Schalper, Scott Gettinger, Amit Mahajan, Roy S. Herbst, Anne C. Chiang +19 more

A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better

Molecular Cancer(2023)10.1186/s12943-023-01884-x

N/A

0.635DataRank · unranked

14 citations

Sarah A. Weiss, Irina Krykbaeva, Rihao Qu, Ioannis Vathiotis, Myrto Moutafi +18 more

Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti–CTLA-4 in renal cell carcinoma

JCI Insight(2024)10.1172/jci.insight.184545

N/A

0.466DataRank · unranked

14 citations

Dijana Djureinovic, David Su, Lin Zhang, Benjamin Y. Lu, Larisa Kamga +8 more

Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells

Cancers(2021)10.3390/cancers13051049

N/A

0DataRank · unranked

14 citations

Chetan K. Rane, Christopher R. Zito, Sarah A. Weiss, Shlomit Jessel, Liliana E. Lucca +9 more

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance

Frontiers in Oncology(2022)10.3389/fonc.2022.990367

N/A

0DataRank · unranked

20 citations

Ross D. Merkin, Myrto Moutafi, Sandra Martinez, Adebowale Adeniran, Deepika Kumar +5 more

Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma

Cellular and Molecular Life Sciences(2022)10.1007/s00018-022-04364-5

N/A

0DataRank · unranked

13 citations

Hongyi Zhang, Christopher R. Zito, Chetan K. Rane, Xianyong Ma, Olivia K. Provance +8 more

Inhibition of renalase drives tumour rejection by promoting T cell activation

European Journal of Cancer(2022)10.1016/j.ejca.2022.01.002

N/A

0DataRank · unranked

12 citations

Shlomit Jessel, Rihao Qu, Yuval Kluger, Tian-Min Chen, Lindsay Hollander +10 more

Coupled fibromodulin and SOX2 signaling as a critical regulator of distant metastasis initiation in melanoma

Research Square(2022)10.21203/rs.3.rs-1244262/v1

N/A

0DataRank · unranked

0 citations

Hongyi Zhang, Christopher R. Zito, Chetan K. Rane, Xianyong Ma, Thuy Tran +7 more

Lenvatinib or anti-VEGF in combination with anti–PD-1 differentially augments antitumor activity in melanoma

JCI Insight(2023)10.1172/jci.insight.157347

N/A

0DataRank · unranked

39 citations

Jasmine I. Caulfield, Lin Zhang, David A. Schoenfeld, Dijana Djureinovic, Veronica Chiang +6 more

Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006570

N/A

0DataRank · unranked

19 citations

Lilach Aizenbud, Ana Luisa Perdigoto, Eric Meffre, Lucia B. Jilaveanu, Dominika A. Michalek +7 more

Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases

Journal of Neuro-Oncology(2020)10.1007/s11060-020-03619-0

N/A

0DataRank · unranked

27 citations

Christopher R. Zito, Thuy Tran, Kazuki Heishima, Veronique Neumeister, John J. McGuire +4 more

Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma

Research Square(2023)10.21203/rs.3.rs-3314825/v1

N/A

0DataRank · unranked

2 citations

Dijana Djureinovic, David A. Schoenfeld, Bernadette Marquez‐Nostra, Kelly Olino, Lucia B. Jilaveanu +2 more

Data from C-Raf Is Associated with Disease Progression and Cell Proliferation in a Subset of Melanomas

(2023)10.1158/1078-0432.c.6517974

N/A

0DataRank · unranked

0 citations

Christopher R. Zito, Saadia A. Aziz, Patricia J. Conrad, John C. Schmitz, Mario Sznol +4 more

Data from A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non–Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1

(2023)10.1158/1078-0432.c.6530444

N/A

0DataRank · unranked

0 citations

Dijana Djureinovic, Shlomit Jessel, Irina Krykbaeva, Lin Zhang, Lucia B. Jilaveanu +17 more

Data from Expression of Sorafenib Targets in Melanoma Patients Treated with Carboplatin, Paclitaxel and Sorafenib

(2023)10.1158/1078-0432.c.6517846.v1

N/A

0DataRank · unranked

0 citations

Christopher R. Zito, Sandra J. Lee, Katherine L. Nathanson, Robert L. Camp, David L. Rimm +3 more

Data from Expression of Sorafenib Targets in Melanoma Patients Treated with Carboplatin, Paclitaxel and Sorafenib

(2023)10.1158/1078-0432.c.6517846

N/A

0DataRank · unranked

0 citations

Christopher R. Zito, Sandra J. Lee, Katherine L. Nathanson, Robert L. Camp, David L. Rimm +3 more

Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma

JCO Precision Oncology(2024)10.1200/po.23.00702

N/A

0DataRank · unranked

12 citations

Dijana Djureinovic, David A. Schoenfeld, Bernadette Marquez‐Nostra, Kelly Olino, Lucia B. Jilaveanu +2 more

GP100 expression is variable in intensity in melanoma

Cancer Immunology Immunotherapy(2024)10.1007/s00262-024-03776-5

N/A

0DataRank · unranked

10 citations

Nitzan Hasson, David Su, Adebowale Adeniran, Keiran S.M. Smalley, Dijana Djureinovic +4 more

TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3

Cancer Immunology Immunotherapy(2024)10.1007/s00262-024-03773-8

N/A

0DataRank · unranked

3 citations

Lucia B. Jilaveanu, Adebowale Adeniran, David Su, Michael E. Hurwitz, David A. Braun +3 more

Ablation of Histone Demethylase KDM5B in Melanoma Augments Anti-Tumor Immunity through Upregulation of Retroelements

Research Square(2020)10.21203/rs.3.rs-87705/v1

N/A

0DataRank · unranked

0 citations

Wesley L. Cai, Xiaoni Liu, Durga Thakral, Goran Micevic, Carmen J. Booth +10 more

MetFinder: A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical Models

Pigment Cell & Melanoma Research(2024)10.1111/pcmr.13195

N/A

0DataRank · unranked

1 citations

Nicolas Coudray, Erol C. Bayraktar, Kristyn Galbraith, George Jour, Arman Alberto Sorin Shadaloey +15 more